185 results on '"Afford S"'
Search Results
2. OC-033 The Tweak and Fn14 Pathway as Potential Mediator of Liver Fibrosis
3. Biliary Epithelial Senescence and Plasticity in Acute Cellular Rejection
4. Activation of CD40 with platelet derived CD154 promotes necro-apoptosis of hepatocytes
5. Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts
6. Liver derived-macrophages direct CD40-CD154 mediated cholangiocyte apoptosis and proinflammatory cytokine release during in-vitro co-culture: 1.6
7. Following the TRAIL from hepatitis C virus and alcohol to fatty liver
8. Biliary epithelial expression of VCAM-1 promotes the survival of lymphocytes in PSC: 8.2
9. Demystified...: Apoptosis
10. An Externally Validated Risk Score for Intrahepatic Cholangiocarcinoma following Surgical Resection: A SEER Database Analysis
11. IDENTIFICATION OF A PUTATIVE NOVEL ADHESION MOLECULE THAT SUPPORTS LYMPHOCYTE ADHESION TO HUMAN HEPATIC ENDOTHELIUM.
12. CD40 expression and function on human hepatocellular carcinoma
13. FAS/FAS-ligand interaction in human colorectal hepatic metastases - a mechanism for hepatocyte destruction to facilitate local tumor invasion?
14. Gel Electrophoresis: Proteins. Dunn MJ. Series: Introduction to Biotechniques
15. Expression of hepatocyte growth factor receptor (c-met) mRNA in primary cultures of human hepatocytes
16. Effects of hepatocyte growth factor on differentiation and cMET receptor expression in the promyelocytic HL60 cell line
17. Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: Study protocol for an open-label, non-randomised, prospective, single-arm trial
18. Effect of Alpha-1-Proteinase Inhibitor on Neutrophil Chemotaxis
19. Combination of hypothermic oxygenated machine perfusion followed by normothermic machine perfusion optimises the reconditioning of marginal human donor livers
20. Factors predicting viability achievement on discarded donor livers submitted to extra-corporeal machine perfusion
21. Viability outcomes for donor livers discarded due to steatosis following extra-corporeal machine perfusion of the liver
22. The effectiveness of a pharmacological intervention for defatting of primary human hepatocytes and its effect on other cell types of the liver: a precursor in-vitro study to the defatting of steatotic human livers using normothermic machine perfusion
23. A merged protocol of hypothermic oxygenated machine perfusion and normothermic machine perfusion optimizes the reconditioning of marginal donor livers
24. SAT-113 - The effectiveness of a pharmacological intervention for defatting of primary human hepatocytes and its effect on other cell types of the liver: a precursor in-vitro study to the defatting of steatotic human livers using normothermic machine perfusion
25. SAT-112 - A merged protocol of hypothermic oxygenated machine perfusion and normothermic machine perfusion optimizes the reconditioning of marginal donor livers
26. 698 FN14 IS EXPRESSED ON NEOPLASTIC CHOLANGIOCYTES IN INTRA-HEPATIC CHOLANGIOCARCINOMA AND PROMOTES NECROSIS AFTER INTERACTION WITH TWEAK
27. 1138 THE FN14/TWEAK RECEPTOR-LIGAND SYSTEM REGULATES HEPATIC STELLATE CELL FUNCTION IN LIVER FIBROSIS
28. Adhesion molecules and alcoholic liver disease
29. PMO-131 FGF inducible protein 14 is upregulated in neovessels during chronic inflammatory liver disease and promotes intrahepatic endothelial cell angiogenesis in vitro following stimulation via tweak
30. PMO-113 FN14 is expressed on cholangiocytes and promotes biliary ductular remodelling via apoptosis and reactive oxygen species after interaction with tweak
31. PMO-118 The effects of th17 cytokines on liver parenchymal cells shape the microenvironment for local generation of TH17/TC17 in inflammatory liver disease
32. Transplantation of Declined Liver Allografts Following Normothermic Ex‐SituEvaluation
33. P98 The effects of Th17 cytokines on liver parenchymal cells shape the microenvironment for local generation of Th17/Tc17 in inflammatory liver disease
34. Gene therapy for hepatocellular carcinoma—teaching old dogs new tricks
35. Hepatocyte Growth Factor Activator (HGF-A) and its Zymogen in Human Placenta
36. The localisation and expression of hepatocyte growth factor (HGF) and its receptor, c-met, in human placenta from the 1st, 2nd, and 3rd trimesters and in the presence of severe IUGR
37. ACTIVATION OF CD40 ON HUMAN HEPATOCYTES INCREASES FAS LIGAND EXPRESSION AND INDUCES APOPTOSIS: A NOVEL MECHANISM OF HEPATOCYTE LOSS IN LIVER ALLOGRAFT REJECTION
38. Hepatocyte Growth Factor (HGF) concentration in matched samples of maternal venous blood and fetal cord venous and arterial blood: Evidence for control of fetal liver development
39. The localisation and expression of Hepatocyte Growth Factor (HGF) and its receptor, , in human placenta throughout gestation and in the presence of severe IUGR
40. Fetal growth restriction and hepatocyte growth factor
41. Influence of ischemia-reperfusion injury on rejection after liver transplantation
42. Gel Electrophoresis: Proteins: Introduction to Biotechniques
43. Localisation of Hepatocyte Growth Factor and its Receptor (c-met) Protein and mRNA in Human Term Placenta
44. Expression of hepatocyte growth factor receptor (c-met) mRNA in primary cultures of human hepatocytes
45. Effects of hepatocyte growth factor on differentiation and cMET receptor expression in the promyelocytic HL60 cell line
46. Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver.
47. Tissue inhibitor of metalloproteinases and collagenase inhibitory activity in lung secretions from patients with chronic obstructive bronchitis: effect of corticosteroid treatment.
48. The immunological measurement of 'free' secretory piece and its relationship to local IgA production.
49. Inhibitory capacity of alpha 1 antitrypsin in lung secretions: variability and the effect of drugs.
50. Apoptosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.